Are Under Eye Fillers Safe

The Short Answer and What Drives Safety

The Short Answer and What Drives Safety

Hyaluronic acid (HA) fillers placed under the eyes have a low complication rate in published studies. A 2020 NIH review of tear-trough filler outcomes described high patient satisfaction with most side effects mild and short-lived. Most patients do well. The safety picture shifts sharply based on who is holding the needle, which filler is used, and where it is placed.

In untrained hands, the same procedure becomes one of the riskier uses of injectable fillers on the face.

The tissue under the eye is thin, vascular, and anchored by ligaments. Arteries that feed the eye sit close to the injection plane. Small volumes change how the skin looks, which is both the appeal and the danger. Filler that migrates upward, settles too shallow, or blocks a small artery causes visible and sometimes serious problems.

This anatomy is why board-certified ophthalmologists, oculoplastic surgeons, and a small group of dermatologists and plastic surgeons with periocular training dominate safe practice in this area.

Only hyaluronic acid fillers belong under the eye, because they are reversible with hyaluronidase, an enzyme that breaks the gel down in hours. Permanent or semi-permanent fillers, calcium hydroxylapatite, and poly-L-lactic acid do not belong here. Mistakes made with reversible HA can be corrected. Mistakes with other products often cannot.

If a provider offers you anything other than an HA filler for the tear trough, ask why, and get a second opinion.

Common and Expected Side Effects

Typical short-term side effects include bruising, swelling, mild tenderness, and small pinpoint redness at injection sites. Across studies, ecchymosis (bruising) occurred in about 12.9% of patients, edema (swelling) in about 9.2%, and lumpiness in about 6.5%, based on a 2025 NIH review of periorbital HA filler complications.

Most of these resolve within one to two weeks without treatment.

Some side effects appear weeks to months after the injection:

  • Persistent swelling that comes and goes
  • Lumps or nodules that develop after the initial settling period
  • Bluish discoloration called the Tyndall effect, from filler placed too superficially
  • Migration of filler into neighboring areas like the lower lid cheek junction
  • Xanthelasma-like yellow patches in a smaller subset of patients

In the 2025 review, delayed swelling affected roughly 42.3% of patients who developed any late issue, and lumps or nodules affected about 25%.

Small bruises fade. Light swelling calms with cold packs, head elevation, and reduced salt. Firm lumps may soften with massage over weeks. Persistent or bothersome lumps, migration, and Tyndall effect all respond to hyaluronidase injection, which dissolves the HA. Any injector performing tear-trough filler should have hyaluronidase on site.

If your injector does not, schedule with someone who does.

Serious Risks to Understand

The most serious risk is vascular occlusion, where filler blocks an artery. Skin blanching, severe pain, and changes in skin color are early signs, and treatment is immediate hyaluronidase flooding. In the face, occlusion can affect skin only; in the eye area, rare cases have been reported in which arterial occlusion caused partial or complete vision loss.

A 2021 NIH systematic review found no published cases of vision loss specifically attributed to tear-trough injection, but the risk is part of why provider choice matters so much.

Bacterial infection at the injection site is uncommon but possible, especially if skin is not prepped thoroughly or if a patient applies makeup too early. Signs include warmth, growing redness, tenderness, and pus. Treatment includes antibiotics and, if filler is involved, often hyaluronidase.

Delayed infections or biofilm formation can present weeks later as recurring swelling or a firm nodule.

In rare cases, the body mounts an inflammatory response to filler that creates a granuloma, a firm nodule with chronic swelling. These are more common with non-HA products but can occur with HA as well. Treatment may involve hyaluronidase, steroid injection, and, rarely, surgical removal.

Patients with autoimmune disease should discuss timing and risks carefully before proceeding.

How to Lower Your Risk

Provider selection is the single biggest lever. Look for:

  • Board certification in ophthalmology, oculoplastic surgery, dermatology, or plastic surgery
  • Specific training in periocular injection, not just general facial filler experience
  • Use of a blunt-tipped cannula in the tear trough
  • Hyaluronidase available on site and staff trained to use it
  • Clear answers about how they handle a vascular event

Under the eye, thinner, more cohesive HA products are usually the right choice. Overfilling is a common error; small amounts produce natural results. If your provider wants to inject large volumes at one visit, ask how they will split the sessions. Two smaller treatments usually look better and heal faster than one large one.

More is not better here.

Help your provider reduce risk:

  • Disclose every medication, including supplements and herbals
  • Pause blood thinners only if your prescribing doctor agrees
  • Skip fish oil, vitamin E, and ginkgo for a week, if safe to do so
  • Avoid alcohol for 24 hours before your appointment
  • Do not schedule filler when you have an active infection, cold sore, or skin breakout nearby

Aftercare That Protects Your Eyes

Keep the area clean and avoid touching or rubbing it. Sleep with your head elevated for the first two nights. Apply cool packs in short intervals for the first 24 hours. Skip intense exercise, hot showers, saunas, and facials for 48 hours. Return to your regular skincare routine after two days if nothing stings.

Mineral makeup after 24 hours is usually safe; heavier makeup after 72 hours.

Contact your provider immediately if you notice any of the following:

  • Severe or worsening pain in the area
  • Blanching or mottled, bluish-white skin
  • Vision changes in either eye
  • Spreading redness, fever, or pus
  • A new, hard lump that grows instead of settling

These are not wait-and-see situations. Same-day evaluation can prevent a minor issue from becoming a serious one.

Most patients look close to normal within a week, with final settling at about four weeks. Touch-ups, if needed, are usually scheduled four to six weeks after the initial visit. Results last anywhere from nine to eighteen months, depending on the product and the individual.

Photos at baseline, week two, and week four help you and your provider judge the result objectively.

Common Questions About Under-Eye Filler Safety

True allergic reactions to modern HA fillers are rare because hyaluronic acid is a substance your body already makes. Reactions to the lidocaine mixed into many fillers, or to the trace cross-linking agents, can occur but are uncommon. Tell your provider about any known drug or anesthetic allergies before treatment.

HA filler can be dissolved with hyaluronidase. Results show within hours to a day or two. Most patients see the treated area return close to baseline. The enzyme is not perfectly selective and can slightly affect nearby filler, so small retouches may be needed after dissolving.

For most healthy adults, yes. Many providers perform both at one appointment. The two work in different ways and tend to complement each other. Coordinate them so the neuromodulator is injected into muscle and the filler is placed in its own plane, to reduce bruising and swelling.

Short domestic flights within 48 hours are usually fine. Long-haul flights can worsen swelling because of cabin dryness and pressure changes. Wait five to seven days before a long international trip when possible, so bruising peaks and fades before you are far from your injector.

HA filler may show a small signal on MRI, but it generally does not interfere with most imaging. Tell your radiologist or technologist that you have had filler, and where, so they can interpret the scan correctly. Avoid scheduling an MRI within the first week after treatment if you can, since swelling may temporarily affect images.

Most providers defer elective filler during pregnancy and breastfeeding because safety data is limited. The procedure is elective, and waiting is the cautious approach. Ask your obstetrician and your injector together before scheduling.

When to Seek Care

If you develop sharp pain, vision changes, spreading redness, or blanching of the skin after any filler, seek urgent care or go to an emergency room. If possible, contact your injector at the same time, so they can meet you or coordinate dissolving the filler quickly.